Abingworth
Venture capital firm · Founded 1973 · London, United Kingdom · London ↗
Abingworth is a transatlantic life sciences investment firm founded in London in 1973. It invests across all stages of development - from start-ups to public companies - in biotechnology and healthcare across Europe and the US, pioneering approaches including Clinical Co-Development and Venture Investments in Public Equities (VIPEs). It was acquired by The Carlyle Group in August 2022.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Abingworth, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$2B
Latest fund
Abingworth Bioventures 8 (ABV 8)$465M · 2021
Funds
LAST CHECKED NOV 2026
Check size
$15M–$30M
Stages
SeedSeries ASeries BGrowth
Sectors
Life Sciences
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
Track record
Misses
Track record
Partners 6
- James Cornwall
Partner
Board seats
No public record - Andrew Sinclair
Managing Director, Head of Publics & Late Stage
Board seats
6 current
- Genghis Lloyd-Harris
Partner
Board seats
9 on record
- Jayson Punwani
Managing Director, Head of Venture
Board seats
6 current
- Bali Muralidhar
Managing Partner, Chief Investment Officer & COO
Board seats
6 current
- Kurt von Emster
Managing Partner
Board seats
9 current
Reputation 1
No reputation score — basis not established for this firm.
- VC Mapping (GilIon) - Abingworth profile: Carlyle acquisition, ~$2B AUM
vc-mapping.gilion.com
Contact
Published sources only
Published contact
- Website
- www.abingworth.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Abingworth. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — AUM of approximately $2B at the August 2022 Carlyle acquisition - tier_2 AUM $2B-$10B rule. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Abingworth — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Reputation
- [2]
FIRM SITE · Abingworth — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
